Drugs / Amolin
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT01032655 | Apr 2009 → Mar 2012 | Helicobacter pylori infectious disease | National Taiwan University Hospital | Completed | No outcome recorded |
| Phase not applicable3 trials · 1 missed | ||||||
| — | NCT05152004 | Sep 2018 → Nov 2021 | Helicobacter pylori infectious disease | Chang Gung Memorial Hospital | Completed | Missed primary |
| — | NCT03383003 | Mar 2016 → May 2018 | Helicobacter pylori infectious disease | Chang Gung Memorial Hospital | Completed | No outcome recorded |
| — | NCT02596620 | Oct 2013 → Oct 2015 | Helicobacter pylori infectious disease | Chang Gung Memorial Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amolin | “D1-7: Nexium (40 mg, bid), Amolin (1 gm, bid)” NCT01032655 ↗ |